Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 44Breast Neoplasms 30Lymphoma 29Sarcoma 27Hodgkin Disease 24Triple Negative Breast Neoplasms 20Burkitt Lymphoma 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Neoplasms 15Lymphoma, Follicular 15Ovarian Neoplasms 14Lymphoma, B-Cell 14Lymphoma, Non-Hodgkin 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, T-Cell, Peripheral 9Endometrial Neoplasms 9Neuroblastoma 7Neoplasm Metastasis 7Lymphoma, Mantle-Cell 7Liposarcoma 7Leukemia 7Fallopian Tube Neoplasms 7Recurrence 6Multiple Myeloma 6Leiomyosarcoma 6Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5Osteosarcoma 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Lymphocytic, Chronic, B-Cell 5Inflammatory Breast Neoplasms 5

Interventions

Methylprednisolone 3Social Determinants of Health 2trastuzumab deruxtecan 1sacituzumab govitecan 1pegaspargase 1Vincristine 1Temozolomide 1Radiotherapy 1Prednisone 1Prednisolone 1Pharmaceutical Services 1Methylprednisolone Hemisuccinate 1Methotrexate 1Mercaptopurine 1Leucovorin 1Irinotecan 1Infliximab 1Hydrocortisone 1Fecal Microbiota Transplantation 1Etoposide 1Drug Therapy 1Doxorubicin 1Dexrazoxane 1Dexamethasone 1Cytarabine 1Cyclophosphamide 1Cefixime 1CTLA-4 Antigen 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Doxorubicin × 1 year × Clear all
NCT00400946 2026-02-13

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Dana-Farber Cancer Institute

Phase 3 Completed
800 enrolled 22 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡